Baxter International (BAX) FCF Margin (2009 - 2026)
Baxter International's (BAX) quarterly FCF Margin came in at 6.11% in Q2 2026, up 3.0% year-over-year from 5.94% in Q2 2025, and up 117.32% quarter-over-quarter from 2.81% in Q1 2026.
Analysis
Baxter International (BAX) FCF Margin (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported FCF Margin for 18 consecutive years, with 6.11% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 3.0% year-over-year to 6.11% in Q2 2026; TTM through Jun 2026 was 7.56%, a 452.0% increase from a year earlier, with the FY2025 full-year figure at 3.9%, down 149.0% from the prior year.
- FCF Margin was 6.11% for Q2 2026 at Baxter International, up from 2.81% in the prior quarter.
- Over five years, FCF Margin peaked at 16.09% in Q4 2023 and troughed at 12.0% in Q1 2025.
- A 5-year average of 6.04% and a median of 5.25% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin tumbled 1413 bps in 2025 and surged 1481 bps in 2026, its largest moves.
- Over 5 years, FCF Margin stood at 13.35% in 2022, then gained by 20 bps to 16.09% in 2023, then declined by 20 bps to 12.93% in 2024, then slumped by 53 bps to 6.09% in 2025, then grew by 0 bps to 6.11% in 2026.
- The last three FCF Margin figures came in at 6.11% (Q2 2026), 2.81% (Q1 2026), and 6.09% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 12.70% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 7.86% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 9.26% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 6.11% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 29.65% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 19.22% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 8.41% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -24.47% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.11% |
| Mar 31, 2026 | 2.81% |
| Jun 30, 2025 | 6.09% |
| Mar 31, 2025 | -12.00% |
| Dec 31, 2024 | 12.93% |
| Sep 30, 2024 | 4.41% |
| Jun 30, 2024 | 1.67% |
| Mar 31, 2024 | 2.13% |
| Dec 31, 2023 | 16.09% |
| Sep 30, 2023 | 13.58% |
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | 12.86% |
| Dec 31, 2022 | 13.35% |
| Sep 30, 2022 | 3.57% |
| Jun 30, 2022 | 3.81% |
| Mar 31, 2022 | 1.91% |
| Dec 31, 2021 | 17.73% |
| Sep 30, 2021 | 15.38% |
| Jun 30, 2021 | 10.30% |
| Mar 31, 2021 | 6.99% |